Ganoderma sinense (Ganoderma sinense): Benefits, Dosage, Safety & Evidence

Frequently asked questions

How does Ganoderma sinense work to support the immune system?

Ganoderma sinense exerts its effects through bioactive polysaccharides and triterpenoids, specifically ganoderic acids and ganosinensosides. These compounds modulate immune function by activating macrophages and enhancing natural killer cell activity. Additionally, the herb possesses antioxidant properties that reduce oxidative stress. While the specific mechanism for Black Reishi requires more human trials, Evidence Level C suggests these actions contribute to its adaptogenic and immune-supporting properties, distinguishing it chemically from Red Reishi.

Does Ganoderma sinense interact with blood thinners or immunosuppressants?

Yes, Ganoderma sinense carries significant interaction risks. Due to its potential to inhibit platelet aggregation, it should not be combined with anticoagulants like warfarin, as this increases bleeding risk. Furthermore, because the polysaccharides in Ganoderma sinense stimulate immune activity, they may counteract the effects of immunosuppressant drugs. Patients on these medications should avoid this herb unless strictly supervised by a qualified healthcare provider.

What is the recommended daily dosage for Ganoderma sinense?

The standard adult dosage for Ganoderma sinense is 3 to 9 grams of dried mushroom daily, usually taken as a decoction or powder. For standardized extracts, a typical dose is 500 mg per day. Because the concentration of active compounds like beta-glucans can vary between products, users should follow specific manufacturer guidelines. It is advisable to start with a lower dose to minimize initial side effects like dizziness.

Is Ganoderma sinense safe to take during pregnancy?

No, Ganoderma sinense is considered unsafe during pregnancy and breastfeeding. Due to a lack of safety data and its potential immune-modulating and anti-platelet effects, use is contraindicated for expecting mothers. Traditional sources and current safety guidelines recommend avoiding this herb to prevent unforeseen complications with fetal development or pregnancy maintenance. Women who are pregnant or trying to conceive should consult a doctor before use.

What are the common side effects of Ganoderma sinense?

Common side effects of Ganoderma sinense are generally mild and may include gastrointestinal upset, such as nausea or diarrhea. Some users experience dizziness or a slight headache during the first few days of supplementation as the body adapts to the adaptogenic compounds. These symptoms typically resolve on their own. To minimize discomfort, it is recommended to take the herb with food and ensure adequate hydration.

PubMed-compiled information sheet

This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.

Compiled from 30 PubMed articles · model: gemma4:31b

Summary

Ganoderma sinense is a medicinal macrofungus used in traditional Chinese medicine for over 2000 years, recognized for its immunomodulatory and antitumor properties [PMID:31030747, PMID:37064273, PMID:37903715].

Background

Ganoderma sinense, also known as 'Zizhi' or purple 'Lingzhi', is a member of the polypore fungi genus Ganoderma [PMID:31030747]. It is a basidiomycete medicinal fungus primarily used in East Asia for promoting health and longevity [PMID:37064273].

Traditional uses

It has been used in China for more than 2000 years to improve health, treat numerous diseases, relieve cough and asthma, provide nourishment, and strengthen the body [PMID:31030747, PMID:37903715, PMID:40733790].

Active compounds

Key active compounds include polysaccharides (glycans), terpenoids (specifically lanostane triterpenoids such as ganoderic acids and ganosinensins A-C), steroids, alkaloids, phenols, ergosterol, and coumarin [PMID:25975187, PMID:37064273, PMID:37903715, PMID:19331378].

Mechanism of action

G. sinense polysaccharides may induce apoptosis through the PI3K/AKT pathway [PMID:40733790] and act as Toll-like receptor 4 (TLR4) agonists to trigger immunologic responses [PMID:31442262]. Certain steroids from the fungus have been identified as noncompetitive inhibitors of mutant IDH1, reducing D-2HG concentrations and histone H3K9me3 methylation [PMID:29738972].

Clinical evidence

Evidence CLeukopenia and hematopoietic injury

G. sinense polysaccharide (GSP) tablet is approved by the SFDA in China as an adjunctive therapeutic drug for treating leukopenia and hematopoietic injury caused by concurrent chemo/radiation therapy during cancer treatment [PMID:31030747, PMID:29078264].

Evidence DMalignant tumors

Pharmacological studies indicate antitumor effects; specifically, GSP70-2 showed suppression of tumor growth in 4T1 tumor-bearing mouse models [PMID:37903715, PMID:40733790].

Evidence DTriple-negative breast cancer (TNBC)

The purified polysaccharide GSBP-2 selectively inhibited the proliferation, migration, and invasion of MDA-MB-231 cells in vitro [PMID:38688342].

Safety & adverse effects

General reviews of Ganoderma suggest it is used in clinical practice with few side effects and high safety [PMID:37903715].

Evidence summary

The evidence consists primarily of preclinical in vitro and in vivo animal studies (Level D) and review articles (Level C). While approved as an adjunctive drug in China for specific hematologic conditions, comprehensive clinical trial data in PubMed is limited.

PubMed sources

1.PMID: 31030747 (2019) — Ganoderma sinense polysaccharide: An adjunctive drug used for cancer treatment. · Progress in molecular biology and translational science
2.PMID: 25975187 (2015) — Secondary metabolites from Ganoderma. · Phytochemistry
3.PMID: 39178996 (2024) — Comparative genomics reveals ample evidence to Ganoderma sinense cultivars for molecular identification and new FIP exploration. · Genomics
4.PMID: 40733790 (2025) — Structural feature and antitumor activity of a N-acetylglucosamine containing polysaccharide from Ganoderma sinense. · Carbohydrate polymers
5.PMID: 37903715 (2023) — A Comprehensive Review on the Chemical Composition, Pharmacology and Clinical Applications of Ganoderma. · The American journal of Chinese medicine

Ganoderma sinense

Sources & Citations

Calculate a safe dose of Ganoderma sinense